MedPath

Effects of Peptides Derived From Fermented Milk on Blood Pressure Regulation System in Healthy Volunteers.

Phase 1
Terminated
Conditions
Healthy
Registration Number
NCT00399737
Lead Sponsor
Assistance Publique - H么pitaux de Paris
Brief Summary

Several milk proteins are precursors of peptides, released during fermentation, which possess various biochemical and physiological properties. Among them, some peptides have been reported to inhibit angiotensin-converting enzyme (ACE) in vitro (an enzyme implicated in blood pressure regulation) and to lower blood pressure (BP). in hypertensive rats and in a small sample of patients with hypertension. One possible mechanism for the BP lowering effect is inhibition of ACE. Prior investigating BP lowering effect of these peptides in a large cohort of hypertensive patients, it is necessary to assess in depth their potency to inhibit ACE in vivo in humans and to compare it to that induced by a well-known ACE inhibitor.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
12
Inclusion Criteria
  • Healthy male volunteers
  • aged between 18 and 35 years
  • informed written consent
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
ACE activity
Secondary Outcome Measures
NameTimeMethod
kinetics/dynamics

Trial Locations

Locations (1)

Clinical Investigation Center 920, H么pital Europ茅en Georges Pompidou

馃嚝馃嚪

Paris, France

漏 Copyright 2025. All Rights Reserved by MedPath